US80105N1054
US80105N1054
Sanofi
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 96.01B EUR | 51.79B EUR | 57.72B EUR | 58.52B EUR |
Enterprise Value | 113.98B EUR | 69.02B EUR | 72.19B EUR | 71.19B EUR |
Valuation Multiples | ||||
Trailing P/E | 21.2x | 13.09x | 7.64x | 9.85x |
Forward P/E | 7.59x | -- | -- | -- |
Price to Sales | 1.96x | 1.06x | 1.22x | 1.62x |
Price to Book | 1.22x | 0.75x | 0.79x | 0.82x |
EV/Revenue | 2.33x | 1.41x | 1.52x | 1.97x |
EV/EBITDA | 8.42x | 5.48x | 6.01x | 7.79x |
Price to FCF (P/FCF) | 15.24x | 7.39x | 8.49x | 11.43x |
EV/FCF | 18.1x | 9.85x | 10.61x | 13.91x |
FCF Yield | 6.56% | 13.52% | 11.79% | 8.75% |